ID Name Structure References (top 5) Molecular Target(s)
1ID:7035
BETA-CARBOLINE


NSC#:84417
Aldrich#:N6252

Freqency:
in 2 ingredients:

  • 275
  • 484
  • in 14 recipes:

  • 8
  • 10
  • 17
  • 21
  • 23
  • 30
  • 43
  • 53
  • 109
  • 117
  • 123
  • 178
  • 180
  • 184

  • Properties
    C11H8N2    168.2





    1:  Crawford LM Jr.
    From the Food and Drug Administration.
    JAMA.    impact factor:   15.402
    2002;  288(6): 688

    2:  Berman SM, Chang L, Suyenobu B, Derbyshire SW, Stains J, Fitzgerald L, Mandelkern M, Hamm L, Vogt B, Naliboff BD, Mayer EA.
    Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron.
    Gastroenterology.    impact factor:   12.182
    2002;  123(4): 969-77

    3:  Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE, McKinzie S, Urrutia R.
    Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome.
    Gastroenterology.    impact factor:   12.182
    2002;  123(2): 425-32

    4:  McCarthy M.
    FDA recommends bringing controversial IBS drug back.
    Lancet.    impact factor:   10.197
    2002;  359(9316): 1491-2

    5:  McCarthy M.
    FDA allows controversial bowel drug back on to market.
    Lancet.    impact factor:   10.197
    2002;  359(9323): 2095

     
    Time used: 62 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005